3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Type2diabetes: new trials by email Literature Review of Type2diabetes trials Research Report on Type2diabetes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes Dorzagliatin tablets - Type2diabetes | Phase 4 | Completed | Hua Medicine Limited | 2024 | 2024-01-17 | 2026-07-10 |
| Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM Henagliflozin, Continuous Subcutaneous Insulin Infusion - Type2diabetes | Phase 4 | Completed | First Affiliated Hospital of Guangxi Medical University | 210 | 2023-03-01 | 2025-03-12 |
| Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes Dapagliflozin, Glargine - Type2diabetes, Coronary Artery Disease | Phase 4 | Completed | Medanta, The Medicity, India | 250 | 2022-07-29 | 2023-10-19 |
Coronary Artery Disease (1) · Diabetes Mellitus, Type 2 (1)
Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Heart Diseases (1) · Metabolic Diseases (1) · Myocardial Ischemia (1) · Nutritional and Metabolic Diseases (1) · Vascular Diseases (1)
Dorzagliatin (1) · Insulin Glargine (1) · Insulin Lispro (1) · dapagliflozin (1) · henagliflozin (1)
First Affiliated Hospital of Guangxi Medical University (1) · Hua Medicine Limited (1) · Medanta, The Medicity, India (1)
China (2) · India (1)